AGL 40.18 Increased By ▲ 0.18 (0.45%)
AIRLINK 127.31 Increased By ▲ 0.27 (0.21%)
BOP 6.64 Decreased By ▼ -0.03 (-0.45%)
CNERGY 4.50 Decreased By ▼ -0.01 (-0.22%)
DCL 8.57 Increased By ▲ 0.02 (0.23%)
DFML 41.97 Increased By ▲ 0.53 (1.28%)
DGKC 87.75 Increased By ▲ 0.90 (1.04%)
FCCL 32.70 Increased By ▲ 0.42 (1.3%)
FFBL 65.21 Increased By ▲ 0.41 (0.63%)
FFL 10.33 Increased By ▲ 0.08 (0.78%)
HUBC 109.35 Decreased By ▼ -0.22 (-0.2%)
HUMNL 14.73 Increased By ▲ 0.05 (0.34%)
KEL 5.13 Increased By ▲ 0.08 (1.58%)
KOSM 7.54 Increased By ▲ 0.08 (1.07%)
MLCF 41.85 Increased By ▲ 0.47 (1.14%)
NBP 59.90 Decreased By ▼ -0.51 (-0.84%)
OGDC 193.85 Increased By ▲ 3.75 (1.97%)
PAEL 28.25 Increased By ▲ 0.42 (1.51%)
PIBTL 7.83 No Change ▼ 0.00 (0%)
PPL 151.95 Increased By ▲ 1.89 (1.26%)
PRL 26.63 Decreased By ▼ -0.25 (-0.93%)
PTC 16.11 Increased By ▲ 0.04 (0.25%)
SEARL 85.60 Decreased By ▼ -0.40 (-0.47%)
TELE 7.65 Decreased By ▼ -0.06 (-0.78%)
TOMCL 35.50 Increased By ▲ 0.09 (0.25%)
TPLP 8.14 Increased By ▲ 0.02 (0.25%)
TREET 16.09 Decreased By ▼ -0.32 (-1.95%)
TRG 52.80 Decreased By ▼ -0.49 (-0.92%)
UNITY 26.40 Increased By ▲ 0.24 (0.92%)
WTL 1.26 No Change ▼ 0.00 (0%)
BR100 9,957 Increased By 73.1 (0.74%)
BR30 30,925 Increased By 325.2 (1.06%)
KSE100 93,860 Increased By 504.3 (0.54%)
KSE30 29,086 Increased By 154.7 (0.53%)

More than 130 therapies are being investigated as possible treatments for the coronavirus, a leading pharmaceutical industry association said Thursday.

Unprecedented efforts to collaborate across the pharmaceutical industry have significantly accelerated the search for safe and effective treatments for the novel coronavirus, the International Federation of Pharmaceutical Manufacturers and Associations said.

"Over 130 COVID-19 therapeutics are under investigation," IFPMA director Thomas Cueni told a virtual briefing, along with a number of pharmaceutical company executives.

The team detailed work on different therapies currently being considered, including anti-malarials, anti-virals, immunotherapies and plasma treatments. Cueni said 77 of them were existing drugs being tested to see if they could be repurposed for use against COVID-19, while 68 were new treatments.

Most were still in the early stages of testing, he said, adding that more than 25 clinical trials had already begun.

"This is really good news for all of us, because we do hope that sooner rather than later we will see first successes in containing and treating COVID-19," he said.

Copyright Agence France-Presse, 2020

Comments

Comments are closed.